BiotechTube

Sublingual film containing BXCL501 (Dexmedetomidine) + Placebo film

Phase 1Completed
0 watching 0 views this week💤 Quiet
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Agitation

Conditions

Agitation, Schizophrenia

Trial Timeline

May 22, 2019 → Jul 31, 2019

NCT ID
NCT04010305

About Sublingual film containing BXCL501 (Dexmedetomidine) + Placebo film

Sublingual film containing BXCL501 (Dexmedetomidine) + Placebo film is a phase 1 stage product being developed by BioXcel Therapeutics for Agitation. The current trial status is completed. This product is registered under clinical trial identifier NCT04010305. Target conditions include Agitation, Schizophrenia.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT04010305Phase 1Completed

Competing Products

20 competing products in Agitation

See all competitors
ProductCompanyStageHype Score
ONO-2020 + PlaceboOno PharmaceuticalPhase 2
52
Quetiapine + Haloperidol + Lorazepam + CogentinAstraZenecaApproved
85
Brexpiprazole, OPC-34712LundbeckPhase 3
74
Brexpiprazole, OPC-34712 + Placebo Oral TabletLundbeckPhase 3
74
BrexpiprazoleLundbeckPhase 3
74
AXS-05 (dextromethorphan-bupropion) + PlaceboAxsome TherapeuticsPhase 3
74
AXS-05 + Bupropion + PlaceboAxsome TherapeuticsPhase 2/3
62
AXS-05 (dextromethorphan-bupropion)Axsome TherapeuticsPhase 3
74
AXS-05 + PlaceboAxsome TherapeuticsPhase 3
74
AXS-05 + PlaceboAxsome TherapeuticsPhase 3
74
Pimavanserin 34 mg + Pimavanserin 20 mgAcadia PharmaceuticalsPhase 2
47
PimavanserinAcadia PharmaceuticalsPhase 2
47
Sublingual film containing Dexmedetomidine (BXCL501) + Placebo FilmBioXcel TherapeuticsPhase 3
69
BXCL501 + Matching PlaceboBioXcel TherapeuticsPhase 3
69
BXCL501 + Matching PlaceboBioXcel TherapeuticsPhase 3
69
BXCL501 + Matching PlaceboBioXcel TherapeuticsPhase 3
69
Sublingual film containing dexmedetomidine (BXCL501) + Placebo FilmBioXcel TherapeuticsPhase 3
69
BXCL501 + BXCL501 + Placebo filmBioXcel TherapeuticsPhase 2
44
BXCL501 + Placebo filmBioXcel TherapeuticsPhase 2
44
Sublingual film containing Dexmedetomidine + Sublingual Placebo FilmBioXcel TherapeuticsPhase 1/2
33

Other Products from BioXcel Therapeutics

Sublingual film containing IgalmiApproved
77
Dexmedetomidine + Lorazepam 2 MG/MLApproved
77
Sublingual film containing Dexmedetomidine (BXCL501) + Placebo FilmPhase 3
69
BXCL501 + Matching PlaceboPhase 3
69
BXCL501 + Matching PlaceboPhase 3
69